Last updated 2026-07-26
- Raised $14M Series C led by Eckuity, Jun 2022
- Raised $1M Series A led by Zohar Zisapel (Late), Jul 2016
- Raised Series B led by HCS Capital, Aug 2019
Total raised
$15.0M
Last: Undisclosed Round 2022-07
Stage
Series C
Founded
2012
Headcount
8
HQ
Kiryat Ono, Israel
Sector
Health Tech & Life Sciences
About
Sanoculis is an Israeli ophthalmic medical device company specializing in proprietary, stentless, minimally invasive solutions for glaucoma angle surgeries. Their mission is to deliver innovative stent-free technology platforms that enhance the standard of care and improve outcomes for patients with glaucoma. They have developed devices like MIMS® (Minimally Invasive Micro Sclerostomy) and MINT® (Minimally Invasive Nasal Trabeculostomy) which create drainage pathways in the eye to reduce intraocular pressure without permanent implants.
Funding history · 3 rounds · $15.0M total
2022-06
C Round
$14.0M
★ Eckuity★ Bausch + Lomb★ Infinity Group
2019-08
B Round
Undisclosed
★ HCS Capital★ BIOLIGHT Life Sciences
2016-07
A Round
$1.0M
★ Zohar Zisapel (Late)
Headcount over time
From 3 (2020-11) to 8 (2025-12) · +5 (+167%) · 10 points · source: Finder history + radar grounding
Q&A
- What is Sanoculis's primary focus?
- Sanoculis specializes in developing a minimally invasive surgical device for glaucoma treatment, specifically its Minimally Invasive Micro Sclerostomy (MIMS) solution.
- When was Sanoculis founded?
- Sanoculis was founded in February 2012.
- What is the total amount of funding Sanoculis has raised to date?
- Sanoculis has raised a total of $18,500,000 USD.
- When was Sanoculis's most recent funding round and who were the investors?
- Sanoculis's most recent funding round occurred in July 2022, with participation from Bausch + Lomb and Eckuity.
- What is the current stage of Sanoculis's funding?
- Sanoculis is currently in its Series C funding stage.
- Who are the co-founders of Sanoculis?
- The co-founders of Sanoculis are Nir Israeli (CEO), Vadim Shmukler (CTO), and Dr. Yoseph Glovinsky (Medical Director).
- When did Sanoculis receive CE marking for its MIMS device?
- Sanoculis was granted CE marking for its MIMS device and procedure in March 2017.
Team · 3
Nir Israeli
Founder · Co-founder & CEO
Yoseph Glovinsky
Founder · Co-founder & Chief Medical Officer
Vadim Shmukler
Founder · Co-founder & COO&CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
minimally-invasivesurgeryglaucomahospitalssurgeonsophthalmologymedical-deviceshealthcare-providerseye-diseasesclinicstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sanoculis.com |
|---|---|
| linkedin.com/company/68842608 | |
| YouTube | youtube.com/channel/UCT1KBtmpyTEvqDlwL5BG6mQ |
| Wikidata | wikidata.org/wiki/Q140045970 |
Identifiers & details
| Legal name | Sanoculis Ltd. |
|---|---|
| Founded | 2012 |
| Employees (exact) | 8 |
| Wikidata QID | Q140045970 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | sanoculis.com |
|---|
Wikidata
| QID | Q140045970 |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514733724 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-02-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (1), people (2), other (1) |
| Registered address | לנדאו 10 קריית אונו |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-15 | העברת מניות |
| 2025-10-13 | עדכון דירקטורים-הוספת דירקטור |
| 2025-10-13 | עדכון דירקטורים-הסרת דירקטור |
| 2026-02-02 | הוספה/עדכון/הסרה של צו עיקול |